Clinical Research Directory
Browse clinical research sites, groups, and studies.
Tomosynthesis vs. Contrast-Enhanced Mammography in Women With Personal History of Breast Cancer in Western Pennsylvania
Sponsor: Wendie Berg
Summary
This is a prospective clinical trial that will examine if contrast-enhanced mammography substantially improves breast cancer detection compared to mammography with tomosynthesis, with minimal increase in false-positives, in women with a personal history of breast cancer.
Official title: Improving Surveillance of Women With Personal History of Breast Cancer Using Contrast-Enhanced Mammography (CEM)
Key Details
Gender
FEMALE
Age Range
30 Years - 85 Years
Study Type
INTERVENTIONAL
Enrollment
1647
Start Date
2019-10-23
Completion Date
2028-12-30
Last Updated
2026-03-09
Healthy Volunteers
Yes
Interventions
Contrast-enhanced mammogram
Contrast-enhanced mammography (CEM) is a new FDA-approved exam that is similar to magnetic resonance imaging (MRI) in depicting breast cancers due to increased and leaky blood vessels. Contrast-enhanced mammography is used as an adjunct following mammography and/or ultrasound examinations to localize a known or suspected lesion.
Locations (3)
Magee Womancare Passavant Cranberry
Cranberry Township, Pennsylvania, United States
Magee Womancare Monroeville
Monroeville, Pennsylvania, United States
Magee Womens Hospital
Pittsburgh, Pennsylvania, United States